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Abstract Maternal obesity during pregnancy is an
important public health problem in Western countries.
Currently, obesity prevalence rates in pregnant women are
estimated to be as high as 30 %. In addition, approximately
40 % of women gain an excessive amount of weight during
pregnancy in Western countries. An accumulating body of
evidence suggests a long-term impact of maternal obesity
and excessive weight gain during pregnancy on adiposity,
cardiovascular and metabolic related health outcomes in
the offspring in fetal life, childhood and adulthood. In this
review, we discuss results from recent studies, potential
underlying mechanisms and challenges for future epi-
demiological studies.
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Introduction
Obesity, cardiovascular disease and type 2 diabetes are
major public health problems. These common diseases
have a large impact on morbidity and mortality in the
general adult population [1–4]. Various socio-demographic
and lifestyle-related risk factors for these diseases have
been identified in both childhood and adulthood, of which
many have been published in this journal [5–26]. Also,
adverse exposures during the fetal and early postnatal
period may influence the risk of adverse health outcomes in
later life [27]. Previous epidemiological studies have
shown that both low and high birth weight are associated
with increased risks of obesity, cardiovascular disease and
type 2 diabetes in later life [27–31]. These findings are
supported by experimental animal studies [27, 32]. Thus,
previous research suggests that both restricted and exces-
sive nutritional in utero environments may lead to cardio-
vascular disease in later life.
In Western countries, maternal obesity during pregnancy
is an important adverse risk factor for an excessive nutri-
tional in utero environment [33, 34]. Currently, the obesity
prevalence rate in pregnant women is estimated to be as
high as 30 % [35, 36]. Also, based on the US Institute of
Medicine (IOM) guidelines, approximately 40 % of
women gain an excessive amount of weight during preg-
nancy in Western countries [37]. The IOM guidelines
define optimal ranges of maternal weight gain during
pregnancy according to a mother’s prepregnancy body
mass index, and have been established based on evidence
from observational studies that relate gestational weight
gain to various maternal and offspring outcomes (Table 1)
[37].
As described previously, both maternal prepregnancy
obesity and excessive gestational weight gain seem to have
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persistent effects on various childhood outcomes [38]. This
review update is focused on the associations of maternal
obesity and excessive weight gain during pregnancy with
specifically cardiovascular and metabolic development in
the offspring from fetal life until adulthood. Results from
recent studies, methodological considerations, potential
underlying mechanisms and challenges for future studies
are discussed.
Fetal development
Maternal prepregnancy obesity and excessive weight gain
during pregnancy are important risk factors for a variety of
adverse fetal outcomes (Table 2). A meta-analysis based on
published results from 9 observational studies showed that the
unadjusted odds ratios of a stillbirth were 1.47 (95 % confi-
dence interval (CI) 1.08–1.94) and 2.07 (95 % CI 1.59–2.74)
among overweight and obese pregnant women, respectively,
compared with normal-weight pregnant women [39]. When
this meta-analysis was restricted to studies that performed
adjusted analyses, results did not materially change. In line
with this meta-analysis, a study among 1857,822 live single
births in Sweden showed that a higher maternal body mass
index in early pregnancy was associated with an increased
risk of infant mortality, especially among term births
(C37 weeks) [40]. This association was mainly explained by
congenital anomalies, birth asphyxia, other neonatal mor-
bidities, sudden infant death syndrome or infections [40]. A
meta-analysis among 18 observational studies showed that
maternal obesity was associated with an increased risk of a
number of congenital anomalies, including neural tube
defects, cardiovascular anomalies, cleft palate, hydrocephaly
and limb reduction anomalies [41].
It is well-known that maternal prepregnancy obesity and
excessive gestational weight gain are associated with an
increased risk of large-size-for gestational age at birth [42,
43]. A recent meta-analysis among 13 studies showed that,
as compared to maternal prepregnancy normal weight,
maternal prepregnancy obesity was associated with a
twofold higher risk of delivering a large size for gestational
age infant [42]. Studies using more detailed maternal
weight and fetal growth measurements showed that a
higher maternal prepregnancy body mass index was asso-
ciated with a higher estimated fetal weight from second
trimester onwards, with stronger associations at older
gestational age [44]. Especially higher second and trimester
maternal weight gain seem to be associated with an
increased risk of large size for gestational age at birth [45,
46]. Furthermore, multiple observational studies have
reported that maternal prepregnancy obesity and excessive
gestational weight gain are associated with increased risks
of low Apgar score, neonatal hypoglycemia and referral to
neonatal intensive care unit [47]. Recently, a meta-analysis
Table 1 Institute of medicine criteria for gestational weight gain
Recommended gestational weight gain defined according to the Institute of Medicine Criteria
Prepregnancy body mass index Recommended amount of total gestational weight gain in kg
Underweight (body mass index\18.5 kg/m2) 12.5–18
Normal weight (body mass index C18.5–24.9 kg/m2) 11.5–16
Overweight (body mass index C25.0–29.9 kg/m2) 7–11.5
Obesity (body mass index C30.0 kg/m2) 5–9
Recommended gestational weight gain guidelines according to women’s prepregnancy body mass index. Adapted from the IOM criteria [37]
Table 2 Adverse offspring outcomes of maternal obesity during pregnancy
Fetal outcomes Childhood outcomes Adult outcomes
Stillbirth
Neonatal death
Congenital anomalies
Large size for gestational age at birth
Neonatal hypoglycemia
Referral to neonatal intensive care unit
Obesity
Adverse body composition
Increased blood pressure
Adverse lipid profile
Increased inflammatory markers
Impaired insulin/glucose homoeostasis
Obesity
Increased blood pressure
Adverse lipid profile
Impaired insulin/glucose homoeostasis
Premature mortality
Cardiovascular and metabolic consequences during fetal life, childhood and adulthood of maternal prepregnancy obesity or excessive gestational
weight gain
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of multiple randomized controlled trials showed that diet-
ary and physical activity interventions aimed at reducing
maternal weight gain during pregnancy may lead to small
reductions in the amount of gestational weight gain and to
lower risks of adverse fetal outcomes [48].
Fewer studies assessed the direct influence of maternal
obesity during pregnancy on placental and fetal cardio-
vascular and metabolic development. It has been shown
that maternal prepregnancy obesity is associated with
higher placental weight, placental vascular dysfunction,
placental inflammation and alterations in placental trans-
porters activity and mitochondrial activity [49–55]. A study
among 1035 mother-infant pairs showed that placental
weight partially mediates the effect of maternal prepreg-
nancy obesity and excessive gestational weight gain on
birth weight [49]. Higher maternal prepregnancy body
mass index and gestational weight gain have been associ-
ated with higher leptin and C-peptide levels in cord blood
[56–59]. The associations of maternal body mass index and
weight gain with detailed embryonic and fetal cardiovas-
cular development remain to be studied.
Thus, both maternal prepregnancy obesity and excessive
gestational weight gain lead to increased risks of adverse
fetal outcomes. Overall, maternal prepregnancy obesity
appears to be more strongly associated with adverse fetal
outcomes than excessive maternal gestational weight gain
[45, 47].
Cardiovascular and metabolic development
in childhood
Maternal prepregnancy obesity and excessive gestational
weight gain are associated with an increased risk of obesity
in childhood and adolescence (Table 2). A meta-analysis
among 4 studies showed that maternal prepregnancy obe-
sity was associated with a threefold higher risk of child-
hood obesity [60]. Similarly, a meta-analysis among 12
studies showed that as compared to a recommended
amount of gestational weight gain according to the IOM
criteria, excessive gestational weight gain was associated
with a 33 % increased risk of childhood obesity [61]. The
associations of maternal obesity during pregnancy with
more detailed childhood fat mass measures have also been
studied. Several studies have shown that a higher maternal
prepregnancy body mass index is associated with a higher
childhood waist circumference and total body fat mass
[62–65]. Result from the Generation R Study in Rotterdam,
The Netherlands, have previously shown among 4871
mother-offspring pairs that a higher maternal prepregnancy
body mass index was associated with a higher childhood
total body fat mass, android/gynoid fat mass ratio,
abdominal subcutaneous fat mass and abdominal
preperitoneal fat mass, a measure of visceral fat mass [62].
Higher maternal weight gain during pregnancy is, inde-
pendent from maternal prepregnancy body mass index,
associated with a higher childhood body mass index, but
associations with other fat mass measures are less consis-
tent [65–70]. Also, both maternal prepregnancy obesity and
excessive gestational weight gain seem to be associated
with a higher blood pressure, adverse lipid profile, insulin
resistance and higher inflammatory markers in childhood
[62, 66, 68, 71, 72]. However, these associations are less
consistent than those for childhood adiposity measures and,
if present, seem to be largely mediated by childhood body
mass index. Importantly, the associations of maternal body
mass index and gestational weight gain with childhood
outcomes seem not to be restricted to maternal obesity or
excessive gestational weight gain, but are present across
the full-range of maternal body mass index and gestational
weight gain.
Several studies aimed to identify critical periods of
maternal weight during pregnancy for childhood outcomes.
A study performed among 5154 UK mother-offspring pairs
showed that especially gestational weight gain in the first
14 weeks of pregnancy was positively associated with
offspring adiposity at 9 years of age [68]. In line with these
findings, a study among 5908 Dutch mother-offspring pairs
showed that independent from maternal prepregnancy
weight and weight gain in later pregnancy, early-pregnancy
weight gain was associated with an adverse cardio-meta-
bolic profile in childhood [66]. A study among 977
mother–child pairs from Greece showed that maternal first
trimester weight gain was associated with an increased risk
of childhood obesity and a higher childhood diastolic blood
pressure [46]. A Finnish study among 6637 mothers and
their adolescent offspring showed that maternal weight
gain of[7 kg in the first 20 weeks of gestation was asso-
ciated with the risk of offspring overweight at the age of
16 years [73]. These studies suggest that especially
maternal weight gain in early pregnancy, when maternal fat
accumulation forms a relatively large component of ges-
tational weight gain, may be a critical period for an adverse
childhood cardiovascular risk profile.
Thus, next to the risks of adverse fetal outcomes,
maternal prepregnancy obesity and excessive gestational
weight gain may lead to increased risks of adiposity and
adverse cardiovascular risk factors in childhood and
adolescence.
Cardiovascular and metabolic disease in adulthood
Multiple studies have shown that a higher maternal
prepregnancy body mass index is associated with a higher
adult body mass index in the offspring, independent from
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socio-demographic and lifestyle-related confounding fac-
tors [74–76] (Table 2). Similarly, increased maternal weight
gain during pregnancy has been associated with higher
offspring adiposity levels in adulthood [74, 76–79]. A study
among 2432 Australians showed that higher maternal ges-
tational weight gain was, independent from maternal
prepregnancy body mass index, associated with a higher
body mass index and tended to be associated with a higher
systolic blood pressure in the offspring at the age 21 years
[79]. A study among 1400 mother-offspring pairs in Jer-
usalem showed that higher maternal prepregnancy body
mass index was associated with a higher body mass index,
waist circumference, blood pressures, insulin and triglyc-
eride levels and lower HDL cholesterol in the offspring aged
32 years [74]. Adjustment for adult concurrent body mass
index fully explained the associations of maternal prepreg-
nancy body mass index with cardio-metabolic risk factors in
adulthood. In the same study, higher maternal gestational
weight gain was only associated with increased adiposity
levels in adult offspring [74]. Another study among 308
Danish mother-offspring pairs, which assessed the associa-
tions of maternal weight gain among normal weight women,
showed that a higher maternal weight gain was associated
with higher insulin levels and leptin levels among male
offspring only [77]. Recently, a study using birth records
from 37,709 participants, showed that a higher maternal
body mass index at the first antenatal visit was associated
with an increased risk of premature all-cause mortality and
hospital admissions for cardiovascular events in adult off-
spring [80]. These associations were not explained by
adjustment for maternal age at delivery, socioeconomic
status, sex of offspring, current age, birth weight, gestation
at delivery, and gestation at measurement of body mass
index. In the adjusted model, the hazard of all-cause mor-
tality in offspring of obese mothers was 1.35 (95 % CI
1.17–1.55), as compared to offspring from mothers with a
normal body mass index. In this study, no information on
gestational weight gain or offspring body mass index was
available [80].
Thus, in line with the associations of maternal
prepregnancy obesity and excessive gestational weight
gain with childhood outcomes, these adverse maternal
exposures are associated with an increased risk of adiposity
and cardiovascular and metabolic disease and mortality in
the adult offspring.
Approaches to assess causality for the observed
associations
The major limitation of these observational studies is
confounding. Various family-based socio-demographic,
nutritional, lifestyle related and genetic characteristics may
explain the observed associations of maternal prepreg-
nancy body mass index and gestational weight gain with
adverse health outcomes in the offspring. Few studies used
more sophisticated study designs to obtain further insight
into the role of confounding in the observed associations,
including sibling comparison studies, maternal and paternal
offspring comparisons analyses, Mendelian randomization
studies, and randomized controlled trial analyses, as
described previously [38].
First, sibling comparison studies enable better control
for potential confounding factors shared within families
[81]. A sibling comparison study among offspring from
mothers who had high levels of prepregnancy weight loss
due to gastrointestinal bypass surgery showed that the risk
of overweight and obesity and adverse cardio-metabolic
risk factors was higher in children born to mothers before
surgery than those born to mothers after surgery [82, 83]. A
sibling comparison study among 42,133 women who had
more than one singleton pregnancy and their 91,045 off-
spring showed that higher maternal total gestational weight
gain was associated with a higher body mass index in
childhood [84]. A study using a sibling comparison design
among 280.866 singleton-born Swedish men showed that a
higher maternal body mass index in early pregnancy was
associated with higher offspring body mass index at the age
of 18 years in the whole cohort and between non-siblings,
but not within-siblings, which suggests that the association
may be explained by confounding environmental charac-
teristics [85]. However, among the same study population
it was shown that among overweight and obese mothers,
higher total gestational weight gain was associated with
higher offspring body mass index at the age of 18 years
among siblings, which suggests a possible intra-uterine
effect for gestational weight gain [86]. A limitation of
sibling comparison studies is that next to the major expo-
sure of interest, such as maternal body mass index, other
related characteristics may also change over time.
Second, several studies compared the strength of asso-
ciations of maternal and paternal body mass index with
offspring outcomes as an aid to further disentangle
underlying mechanisms. Stronger associations for maternal
body mass index suggest direct intrauterine mechanisms,
whereas similar or stronger associations for paternal body
mass index suggest a role for shared family-based, life-
style-related characteristics or genetic factors [87]. Studies
comparing associations of maternal and paternal body mass
index with childhood body mass index have shown con-
flicting results [88]. However, studies examining these
associations with more detailed childhood fat mass mea-
sures and other cardio-metabolic risk factors, have shown
that maternal prepregnancy body mass index tends to be
more strongly associated with childhood total fat mass,
android/gynoid fat mass ratio and clustering of cardio-
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metabolic risk factors than paternal body mass index [62–
64]. These findings suggest that some of the effects of
maternal prepregnancy obesity on offspring outcomes may
be through direct intra-uterine mechanisms.
Third, Mendelian randomization approaches use genetic
variants, known to be robustly associated with the exposure
of interest and not affected by confounding, as an instru-
mental variable for a specific exposure [89]. Associations
of these genetic variants with the outcomes of interest
support causality for these associations. A study among
4091 mother-offspring pairs, showed no association of
maternal FTO with childhood fat mass at the age of 9 years
[64]. Thus far, no other Mendelian randomization studies
on these specific associations have been performed.
Fourth, randomized controlled trials are considered as
the golden standard for causality studies. Because ran-
domized studies are difficult to perform when maternal
prepregnancy obesity and excessive gestational weight
gain are the major exposures of interest, previous studies
focused on influencing determinants of obesity and
excessive gestational weight gain, such as dietary factors
and physical activity levels [48]. Based on results from
randomized controlled trials, it has been suggested that
especially dietary interventions during pregnancy may lead
to a small reduction in the amount of gestational weight
gain [48]. However, whether they also have a beneficial
effect on long-term offspring health outcomes remains
unclear. A small randomized controlled trial among 254
mothers and their children, which provided both dietary
advice and exercise to obese women during pregnancy,
observed no difference in body mass index or metabolic
risk factors in the offspring at the age of 2.8 years, when
compared to the control group and an external reference
group of normal weight women [90].
Altogether, results from studies specifically designed to
explore the causality for the associations of maternal obe-
sity during pregnancy with offspring outcomes are not
conclusive yet.
Programming effects of maternal obesity
during pregnancy
Hypothesis
The mechanisms underlying the associations of maternal
obesity or excessive gestational weight gain with cardio-
vascular and metabolic disease in the offspring are not
known yet. The fetal overnutrition hypothesis suggests that
increased placental transfer of nutrients to the developing
fetus in obese mothers and mothers with high levels of
gestational weight gain, may subsequently affect fetal
development, fetal fat deposition and the development of
the hypothalamic-endocrine system that controls appetite
and energy metabolism [91–93]. These adaptations may
predispose individuals to a greater risk of adverse health
outcomes in later life. Figure 1 shows potential mecha-
nisms that might be involved in the associations of higher
maternal prepregnancy body mass index and gestational
weight gain with the risks of cardiovascular and metabolic
disease in the offspring.
Specific maternal exposures
Maternal prepregnancy obesity and excessive gestational
weight gain are complex traits, which reflect multiple
components. Maternal prepregnancy obesity reflects
maternal nutritional status, fat accumulation and low-grade
inflammation, whereas maternal weight gain during preg-
nancy additionally reflects maternal and amniotic fluid
expansion and growth of the fetus, placenta and uterus
[37].
Maternal prepregnancy obesity is an indicator of a poor
quality maternal diet. Both macronutrients and micronu-
trients intake related to a Western diet may influence fetal
cardiovascular and metabolic development, through influ-
ences on placental transfer and subsequently offspring fat
deposition, adipocyte function, pancreatic function and
food preference [91, 94]. A study among 585 mothers and
their children showed that a maternal diet during pregnancy
high in saturated fat and sugar intake was associated with
an increased risk of offspring obesity [95]. Also, several
studies suggested that a low maternal Omega-3 and high
Omega-6 fatty acids intake and plasma levels are associ-
ated with an increased risk of obesity in the offspring [96–
98]. A study among 906 mother–child pairs showed that
higher maternal dietary glycemic index and glycemic load
in early pregnancy, but not later in pregnancy, were asso-
ciated with higher fat mass in childhood [99]. A study
among approximately 3000 mothers, fathers and their
children showed that maternal dietary intake of proteins,
fat and carbohydrates during pregnancy, but not paternal
dietary intake, was associated with the child’s dietary
intake of the same macronutrients. The associations of
maternal dietary intake during pregnancy with child’s
dietary intake were also stronger than the associations of
maternal postnatal dietary intake, which suggest that in
utero mechanisms may play a role in the programming of
offspring appetite [100]. Altogether, these studies suggest
that various measures reflecting a suboptimal dietary status
in pregnant women are associated with adverse cardio-
vascular and metabolic outcomes in offspring.
Maternal prepregnancy obesity and excessive gesta-
tional weight gain partly reflect maternal fat accumulation,
which is important for fetal development [101]. However,
during pregnancy, fat accumulation predominantly occurs
Maternal obesity during pregnancy and cardiovascular development and disease in the offspring 1145
123
centrally [101]. Central fat accumulation is associated with
an adverse cardiovascular and metabolic risk profile in
adults, including pregnant women [102]. The metabolic
disturbances may involve dyslipidemia and insulin resis-
tance, which leads to higher maternal circulating levels of
free fatty acids, amino acids and glucose, which affect
placental and fetal development [101]. A small study
among 40 pregnant women showed that maternal insulin
secretory response in early pregnancy, but not before or
later in pregnancy, was associated with increased placental
growth [103]. It has been suggested that excessive maternal
nutrition to the developing fetus, especially hyperglycemia,
may lead to teratogenicity in the first trimester of preg-
nancy [104, 105]. Also, gestational diabetes, glycosuria and
higher maternal fasting glucose levels during pregnancy
are associated with higher weight and c-peptide levels at
birth and body mass index, fat mass level, fasting glucose
and insulin levels in the offspring [106–110]. Two sibling
comparison studies, conducted in the Pima of Arizona and
Sweden, respectively, showed that body mass index and the
risk of type 2 diabetes were higher among offspring from
mothers with diabetes during pregnancy, as compared to
their siblings who were born when the mother did not have
diabetes [85, 111]. Small observational studies have sug-
gested that, independent from maternal prepregnancy body
mass index, higher maternal triglyceride and amino acid
levels are associated with a higher birth weight and
neonatal fat mass [112–115]. Thus, maternal fat distribu-
tion and metabolic profile during pregnancy may have
persistent effects on fetal development and cardio-meta-
bolic development in later life.
Low grade systemic inflammation may be involved in
pathways leading from maternal obesity or excessive ges-
tational weight gain to adverse offspring outcomes. Obesity
is associated with low-grade systemic inflammation and
oxidative stress, also during pregnancy [116–118]. Addi-
tionally, pregnancy itself leads to a state of mild maternal
systemic inflammation, which may interact with obesity-
mediated inflammatory mechanisms [119–122]. It has been
shown that maternal inflammatory markers during preg-
nancy correlate with fetal growth and neonatal fat mass
[123, 124], but the effects at older ages are less clear. A
recent study among 439 Danish mother-offspring pairs,
observed no associations of maternal third trimester CRP,
TNF-a, IL-6, and IL-1b with offspring body mass index,
waist circumference, blood pressure and several metabolic
measures at the age of 20 years [125].
Underlying pathways
Both maternal obesity and excessive gestational weight
gain as well as the correlated nutritional, body fat distri-
bution, metabolic and inflammatory exposures may lead to
programming effects in the offspring through several
pathways.
Epigenetic changes in the offspring are likely to play an
important role in developmental programming [126]. Epi-
genetic mechanisms involve a range of modifications to
DNA and associated proteins that together regulate gene
activity [127]. Environmental influences in early life may
induce epigenetic changes, and thereby affect the risk of
cardiovascular and metabolic disease in later life [127].
Fig. 1 Maternal obesity during pregnancy and offspring developmental adaptations (conceptual model for potential underlying mechanisms for
the associations of maternal obesity during pregnancy with adverse cardiovascular and metabolic health outcomes in offspring)
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Although animals studies provide support for epigenetic
modifications due to maternal obesity or a high fat diet,
only few human studies have explored these associations
[126]. Small studies among pregnant women suggested
epigenetic changes of placental genes induced by maternal
obesity and impaired maternal glucose tolerance [121,
128–130]. Also, a human study among 88 mother–child
pairs suggested that maternal weight gain in early preg-
nancy, but not maternal prepregnancy body mass index or
weight gain in later pregnancy, might be associated with
epigenetic modifications in offspring cord blood [131].
Epigenetic modifications as well as other mechanisms may
be involved in adiposity, cardiovascular and metabolic
developmental adaptations.
Offspring from mothers with prepregnancy obesity or
excessive gestational weight gain during pregnancy have
higher fetal growth rates and are at increased risk of being
born large for their gestational age. Higher birth weight is
associated with an increased risk of obesity in later life
[132]. The associations of maternal obesity during preg-
nancy with the risk of obesity in childhood and adulthood
may thus be explained by tracking of body size and fatness
throughout the life course. However, many observational
studies have shown that additional adjustment for birth
weight does not explain the observed associations [38].
This might be explained by birth weight not accurately
reflecting neonatal fat mass, but might also suggest that
other mechanisms play an important role [91]. Animal
studies have suggested that altered adipocyte development
may influence the development of obesity and insulin
resistance in the offspring, as maternal obesity during
pregnancy may affect both offspring adipocyte morphology
and metabolism [92]. Next to altered growth and adipocyte
function, altered appetite control may be a key factor in
developmental programming of obesity. A maternal
hypercalorific diet during pregnancy and overfeeding in the
fetal and early postnatal period is associated with adverse
programming of the hypothalamus, which may lead to
hyperphagia and altered satiety mechanisms [91, 133].
High leptin and insulin levels in the fetal and early post-
natal period are thought to play a central role in this
adverse hypothalamic programming [91].
The associations of maternal prepregnancy body mass
index and gestational weight gain with adverse cardiovas-
cular and metabolic outcomes in the offspring appear to be
largely mediated through offspring obesity. However,
direct cardiovascular and metabolic programming effects
of maternal obesity during pregnancy may also be present
[92]. Animal studies have shown maternal programming
effects on cardiovascular and metabolic outcomes. Mater-
nal obesity and high fat diet during pregnancy are associ-
ated with high blood pressure, endothelial dysfunction,
increased aortic stiffness and cardiac hypertrophy in
rodents [92, 134]. It has been shown that high blood
pressure in offspring occurs, due to selective leptin resis-
tance which increased sympathetic nervous system activity,
before the development of increased adiposity levels and
hyperleptinaemea, which suggests that the selective leptin
resistance was not obesity related but a direct consequence
of the exposure to maternal obesity in early life [134].
Increased maternal glucose transport to the developing
fetus leads to a higher exposure of glucose for the devel-
oping fetal pancreas, which results in acceleration of fetal
pancreatic development [92, 133]. This accelerated pan-
creatic maturation may predispose to premature loss of ß-
cells and consequently lead to impaired glucose and insulin
homoeostatis [133]. Offspring of female rats and mice fed a
high-fat diet during pregnancy have increased triglyceride
levels and oxidative stress in the liver, which may predis-
pose to the development of non-alcohol fatty liver disease,
the hepatic manifestation of the metabolic syndrome [92].
Thus, multiple mechanisms may be involved in the
intra-uterine pathways leading from maternal obesity and
excessive weight gain during pregnancy to long-term
adverse offspring health outcomes.
Perspectives for future epidemiological research
Current evidence from epidemiological studies suggests
that maternal obesity and excessive weight gain during
pregnancy have important adverse consequences on car-
diovascular and metabolic development from fetal life
onwards, leading to disease in later life. Yet, there remain
important issues to be addressed. These include identifi-
cation of the extent of causality of the observed associa-
tions, the underlying exposures and their critical periods,
the developmental adaptations, and the potential for
development of preventive strategies (Table 3).
First, despite extensive adjustment for potential con-
founding factors in these observational studies, residual
confounding may still be an issue. The causality of the
observed associations needs to be further addressed. Large
observational studies that are able to apply more sophisti-
cated methods, such as parent-offspring comparison stud-
ies, sibling comparison studies and Mendelian
randomization-studies are needed to obtain further insight
into the causality of the associations of interest. Long-term
follow-up of participants in trials focused on reducing
maternal weight throughout pregnancy will also provide
further insight into the causality. Large meta-analyses are
needed to obtain further insight into the strength, consis-
tency and independency of the associations.
Second, the underlying mechanisms of the observed
associations of maternal obesity during pregnancy with
offspring health outcomes remain unclear. Animals studies
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have identified multiple pathways that may be involved in
these associations, but these pathways remain largely
unexplored in humans. Maternal prepregnancy obesity and
excessive gestational weight gain are complex traits, which
reflect multiple lifestyle-related and biological components,
which complicates identification of potential underlying
pathways. Future studies may benefit from detailed
assessments of the studied exposures and outcomes
throughout the life-course, which could provide further
insight into potential underlying mechanisms. Studies with
repeated maternal weight measurements during pregnancy
available can identify critical periods of maternal weight
gain. To obtain further insight into the different components
associated with offspring outcomes, studies are needed with
more detailed measurements of maternal nutritional status,
body composition, metabolic and inflammatory measures,
pregnancy-related hemodynamic adaptations and fetal
growth. For the offspring outcomes, more detailed mea-
surements of growth, body composition and cardio-meta-
bolic factors, including cardiac structures, endothelial
function, pulse wave velocity, lipid spectrums and glucose
responses, might also lead to further insight into the
underlying growth, vascular and metabolic mechanisms
present in the observed associations. Since early pregnancy
appears to be a critical period for offspring outcomes,
studies are needed with detailed maternal measurements
from early pregnancy onwards to already assess their
influence on placental and embryonic growth and devel-
opment. Long-term follow up of participants in observa-
tional studies is needed to assess the influence on the risk of
obesity and related cardio-metabolic disorders throughout
the life-course. In addition, it is of interest to conduct fol-
low-up studies of the third generation offspring from these
large observational studies, as this may provide further
insight into the intergenerational effects of maternal obesity
during pregnancy on especially female offspring.
Third, further research is needed focused on prevention
of adverse health outcomes in offspring through optimizing
maternal prepregnancy body mass index, weight gain and
diet during pregnancy. Studies are needed to assess the
optimal amounts of maternal weight gain for short-term
and long-term maternal and offspring health outcomes to
further improve the IOM recommendations for gestational
weight gain. Identification of specific maternal dietary
components associated with offspring health outcomes is
needed to improve maternal dietary recommendations
during pregnancy. Long term follow up of mothers and
their children participating in randomized trials focused on
improving maternal diet and reducing maternal weight
throughout pregnancy will provide insight into the effec-
tiveness of these maternal lifestyle interventions during
pregnancy for improving long-term health of offspring.
Conclusions
Maternal prepregnancy obesity and excessive weight gain
during pregnancy seem to be important risk factors for an
adverse in utero environment and long-term adverse car-
diovascular and metabolic outcomes in the offspring. Well-
designed epidemiological studies are needed to identify the
extent of causality of the observed associations, the
underlying exposures and their critical periods, the devel-
opmental adaptations, and the potential for development of
preventive strategies to improve long-term health outcomes
of offspring.
Acknowledgments The author received funding from the European
Union’s Seventh Framework Programme (FP7/2007-2013), project
Early Nutrition under Grant Agreement No. 289346.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
1. Ritchey MD, Loustalot F, Bowman BA, Hong Y. Trends in
mortality rates by subtypes of heart disease in the United States,
2000–2010. JAMA, J Am Med Assoc. 2014;312(19):2037–9.
2. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-
mass index and mortality among 1.46 million white adults.
N Engl J Med. 2010;363(23):2211–9.
3. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal
adiposity and risk of death in Europe. N Engl J Med.
2008;359(20):2105–20.
Table 3 Key points for future research
Observational studies with a sophisticated study design, such as parent-offspring comparison studies, sibling comparison studies and
Mendelian randomization-studies, are needed to obtain further insight into the causality of the observed associations
Detailed maternal exposures and offspring outcome measurements are needed to obtain further insight into the exposures and their critical
periods, and the underlying mechanisms of the observed associations
Long-term follow-up of participants in trials focused on reducing maternal weight throughout pregnancy is needed for assessment of causality
of the observed associations and the effectiveness of maternal lifestyle interventions during pregnancy for improving long-term health of
offspring
1148 R. Gaillard
123
4. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and car-
diovascular disease: a statement for healthcare professionals
from the American Heart Association. Circulation.
1999;100(10):1134–46.
5. Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D,
Heiss G. Early-life and adult socioeconomic status and inflam-
matory risk markers in adulthood. Eur J Epidemiol.
2007;22(1):55–66.
6. O’Doherty MG, Jorgensen T, Borglykke A, et al. Repeated
measures of body mass index and C-reactive protein in relation
to all-cause mortality and cardiovascular disease: results from
the consortium on health and ageing network of cohorts in
Europe and the United States (CHANCES). Eur J Epidemiol.
2014;29(12):887–97.
7. Gunnell AS, Knuiman MW, Divitini ML, Cormie P. Leisure
time physical activity and long-term cardiovascular and cancer
outcomes: the Busselton Health Study. Eur J Epidemiol.
2014;29(11):851–7.
8. Leenders M, Boshuizen HC, Ferrari P, et al. Fruit and vegetable
intake and cause-specific mortality in the EPIC study. Eur J
Epidemiol. 2014;29(9):639–52.
9. Holtermann A, Mork PJ, Nilsen TI. Hours lying down per day
and mortality from all-causes and cardiovascular disease: the
HUNT Study, Norway. Eur J Epidemiol. 2014;29(8):559–65.
10. Eveborn GW, Schirmer H, Lunde P, Heggelund G, Hansen JB,
Rasmussen K. Assessment of risk factors for developing inci-
dent aortic stenosis: the Tromso Study. Eur J Epidemiol.
2014;29(8):567–75.
11. Etemadi A, Abnet CC, Kamangar F, et al. Impact of body size
and physical activity during adolescence and adult life on
overall and cause-specific mortality in a large cohort study from
Iran. Eur J Epidemiol. 2014;29(2):95–109.
12. Kershaw KN, Droomers M, Robinson WR, Carnethon MR,
Daviglus ML, Monique Verschuren WM. Quantifying the con-
tributions of behavioral and biological risk factors to socioeco-
nomic disparities in coronary heart disease incidence: the
MORGEN study. Eur J Epidemiol. 2013;28(10):807–14.
13. Malerba S, Turati F, Galeone C, et al. A meta-analysis of
prospective studies of coffee consumption and mortality for all
causes, cancers and cardiovascular diseases. Eur J Epidemiol.
2013;28(7):527–39.
14. Novak M, Toren K, Lappas G, et al. Occupational status and
incidences of ischemic and hemorrhagic stroke in Swedish men:
a population-based 35-year prospective follow-up study. Eur J
Epidemiol. 2013;28(8):697–704.
15. Leon DA, Shkolnikov VM, Borinskaya S, et al. Hazardous
alcohol consumption is associated with increased levels of
B-type natriuretic peptide: evidence from two population-based
studies. Eur J Epidemiol. 2013;28(5):393–404.
16. Westerlund A, Bellocco R, Sundstrom J, Adami HO, Akerstedt
T, Trolle Lagerros Y. Sleep characteristics and cardiovascular
events in a large Swedish cohort. Eur J Epidemiol.
2013;28(6):463–73.
17. Threapleton DE, Greenwood DC, Burley VJ, Aldwairji M, Cade
JE. Dietary fibre and cardiovascular disease mortality in the UK
Women’s Cohort Study. Eur J Epidemiol. 2013;28(4):335–46.
18. Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of
future hypertension: meta-analysis of 283,537 participants. Eur J
Epidemiol. 2013;28(3):205–21.
19. Iversen B, Jacobsen BK, Lochen ML. Active and passive
smoking and the risk of myocardial infarction in 24,968 men and
women during 11 year of follow-up: the Tromso Study. Eur J
Epidemiol. 2013;28(8):659–67.
20. Mishra GD, Chiesa F, Goodman A, De Stavola B, Koupil I.
Socio-economic position over the life course and all-cause, and
circulatory diseases mortality at age 50–87 years: results from a
Swedish birth cohort. Eur J Epidemiol. 2013;28(2):139–47.
21. Li K, Monni S, Husing A, et al. Primary preventive potential of
major lifestyle risk factors for acute myocardial infarction in
men: an analysis of the EPIC-Heidelberg cohort. Eur J Epi-
demiol. 2014;29(1):27–34.
22. Demakakos P, Marmot M, Steptoe A. Socioeconomic position
and the incidence of type 2 diabetes: the ELSA study. Eur J
Epidemiol. 2012;27(5):367–78.
23. Claessen H, Brenner H, Drath C, Arndt V. Repeated measures of
body mass index and risk of health related outcomes. Eur J
Epidemiol. 2012;27(3):215–24.
24. Iversen LB, Strandberg-Larsen K, Prescott E, Schnohr P, Rod
NH. Psychosocial risk factors, weight changes and risk of obe-
sity: the Copenhagen City Heart Study. Eur J Epidemiol.
2012;27(2):119–30.
25. Morkedal B, Romundstad PR, Vatten LJ. Informativeness of
indices of blood pressure, obesity and serum lipids in relation to
ischaemic heart disease mortality: the HUNT-II study. Eur J
Epidemiol. 2011;26(6):457–61.
26. Laaksonen MA, Knekt P, Rissanen H, et al. The relative
importance of modifiable potential risk factors of type 2 dia-
betes: a meta-analysis of two cohorts. Eur J Epidemiol.
2010;25(2):115–24.
27. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of
in utero and early-life conditions on adult health and disease.
N Engl J Med. 2008;359(1):61–73.
28. Curhan GC, Chertow GM, Willett WC, et al. Birth weight and
adult hypertension and obesity in women. Circulation.
1996;94(6):1310–5.
29. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL,
Stampfer MJ. Birth weight and adult hypertension, diabetes mel-
litus, and obesity in US men. Circulation. 1996;94(12):3246–50.
30. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and
ischaemic heart disease in England and Wales. Lancet.
1986;1(8489):1077–81.
31. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of
type 2 diabetes: a systematic review. JAMA, J Am Med Assoc.
2008;300(24):2886–97.
32. Pereira TJ, Moyce BL, Kereliuk SM, Dolinsky VW. Influence of
maternal overnutrition and gestational diabetes on the pro-
gramming of metabolic health outcomes in the offspring:
experimental evidence. Biochem Cell Biol. 2014;93:1–14.
33. Haslam DW, James WP. Obes Lancet. 2005;366(9492):1197–209.
34. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional,
and global trends in body-mass index since 1980: systematic
analysis of health examination surveys and epidemiological
studies with 960 country-years and 9.1 million participants.
Lancet. 2011;377(9765):557–67.
35. Huda SS, Brodie LE, Sattar N. Obesity in pregnancy: prevalence
and metabolic consequences. Semin Fetal Neonatal Med.
2010;15(2):70–6.
36. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity
and trends in the distribution of body mass index among US adults,
1999–2010. JAMA, J Am Med Assoc. 2012;307(5):491–7.
37. Institute of Medicine (US) and National Research Council (US)
Committee to Reexamine IOM Pregnancy Weight Guidelines,
Rasmussen KM, Yaktine AL, editors. Weight gain during
pregnancy: reexamining the guidelines. Washington, DC:
National Academies Press; 2009.
38. Gaillard R, Felix JF, Duijts L, Jaddoe VW. Childhood conse-
quences of maternal obesity and excessive weight gain during
pregnancy. Acta Obstet Gynecol Scand. 2014;93(11):1085–9.
39. Chu SY, Kim SY, Lau J, et al. Maternal obesity and risk of still-
birth: a metaanalysis. Am J Obstet Gynecol. 2007;197(3):223–8.
Maternal obesity during pregnancy and cardiovascular development and disease in the offspring 1149
123
40. Johansson S, Villamor E, Altman M, Bonamy AK, Granath F,
Cnattingius S. Maternal overweight and obesity in early preg-
nancy and risk of infant mortality: a population based cohort
study in Sweden. BMJ. 2014;349:g6572.
41. Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal over-
weight and obesity and the risk of congenital anomalies: a
systematic review and meta-analysis. JAMA, J Am Med Assoc.
2009;301(6):636–50.
42. Gaudet L, Ferraro ZM, Wen SW, Walker M. Maternal obesity
and occurrence of fetal macrosomia: a systematic review and
meta-analysis. BioMed Res Int. 2014;2014:640291.
43. Ludwig DS, Currie J. The association between pregnancy
weight gain and birthweight: a within-family comparison. Lan-
cet. 2010;376(9745):984–90.
44. Ay L, Kruithof CJ, Bakker R, et al. Maternal anthropometrics are
associated with fetal size in different periods of pregnancy and at
birth. The Generation R Study. BJOG. 2009;116(7):953–63.
45. Gaillard R, Durmus B, Hofman A, Mackenbach JP, Steegers
EA, Jaddoe VW. Risk factors and outcomes of maternal obesity
and excessive weight gain during pregnancy. Obesity.
2013;21(5):1046–55.
46. Karachaliou M, Georgiou V, Roumeliotaki T, et al. Association
of trimester-specific gestational weight gain with fetal growth,
offspring obesity, and cardiometabolic traits in early childhood.
Am J Obstet Gynecol. 2014;212:502 e1–14.
47. Poston L, Harthoorn LF, Der Van, Beek EM. Contributors to the
IEW. Obesity in pregnancy: implications for the mother and
lifelong health of the child. A consensus statement. Pediatr Res.
2011;69(2):175–80.
48. Thangaratinam S, Rogozinska E, Jolly K, et al. Effects of
interventions in pregnancy on maternal weight and obstetric
outcomes: meta-analysis of randomised evidence. BMJ.
2012;344:e2088.
49. Ouyang F, Parker M, Cerda S, et al. Placental weight mediates
the effects of prenatal factors on fetal growth: the extent differs
by preterm status. Obesity. 2013;21(3):609–20.
50. Ditchfield AM, Desforges M, Mills TA, et al. Maternal obesity
is associated with a reduction in placental taurine transporter
activity. Int J Obes. 2015;39(4):557–64.
51. Mele J, Muralimanoharan S, Maloyan A, Myatt L. Impaired
mitochondrial function in human placenta with increased
maternal adiposity. Am J Physiol Endocrinol Metab.
2014;307(5):E419–25.
52. Huang L, Liu J, Feng L, Chen Y, Zhang J, Wang W. Maternal
prepregnancy obesity is associated with higher risk of placental
pathological lesions. Placenta. 2014;35(8):563–9.
53. Aye IL, Lager S, Ramirez VI, et al. Increasing maternal body
mass index is associated with systemic inflammation in the
mother and the activation of distinct placental inflammatory
pathways. Biol Reprod. 2014;90(6):129.
54. Malti N, Merzouk H, Merzouk SA, et al. Oxidative stress and
maternal obesity: feto-placental unit interaction. Placenta.
2014;35(6):411–6.
55. Zera CA, Seely EW, Wilkins-Haug LE, Lim KH, Parry SI,
McElrath TF. The association of body mass index with serum
angiogenic markers in normal and abnormal pregnancies. Am J
Obstet Gynecol. 2014;211(3):247 e1-7.
56. Karakosta P, Georgiou V, Fthenou E, et al. Maternal weight
status, cord blood leptin and fetal growth: a prospective mother-
child cohort study (Rhea study). Paediatr Perinat Epidemiol.
2013;27(5):461–71.
57. Ferretti G, Cester AM, Bacchetti T, et al. Leptin and paraox-
onase activity in cord blood from obese mothers. J Matern Fetal
Neonatal Med. 2014;27(13):1353–6.
58. Valsamakis G, Papatheodorou DC, Margeli A, et al. First tri-
mester maternal BMI is a positive predictor of cord blood
c-peptide levels while maternal visfatin levels is a negative
predictor of birth weight. Hormones. 2014;13(1):87–94.
59. Catalano PM, McIntyre HD, Cruickshank JK, et al. The
hyperglycemia and adverse pregnancy outcome study: associa-
tions of GDM and obesity with pregnancy outcomes. Diabetes
Care. 2012;35(4):780–6.
60. Yu Z, Han S, Zhu J, Sun X, Ji C, Guo X. Pre-pregnancy body
mass index in relation to infant birth weight and offspring
overweight/obesity: a systematic review and meta-analysis.
PLoS ONE. 2013;8(4):e61627.
61. Tie HT, Xia YY, Zeng YS, et al. Risk of childhood overweight or
obesity associated with excessive weight gain during pregnancy: a
meta-analysis. Arch Gynecol Obstet. 2014;289(2):247–57.
62. Gaillard R, Steegers EA, Duijts L, et al. Childhood car-
diometabolic outcomes of maternal obesity during pregnancy:
the Generation R Study. Hypertension. 2014;63(4):683–91.
63. Catalano PM, Farrell K, Thomas A, et al. Perinatal risk factors
for childhood obesity and metabolic dysregulation. Am J Clin
Nutr. 2009;90(5):1303–13.
64. Lawlor DA, Timpson NJ, Harbord RM, et al. Exploring the
developmental overnutrition hypothesis using parental-offspring
associations and FTO as an instrumental variable. PLoS Med.
2008;5(3):e33.
65. Robinson SM, Crozier SR, Harvey NC, et al. Modifiable early-
life risk factors for childhood adiposity and overweight: an
analysis of their combined impact and potential for prevention.
Am J Clin Nutr. 2015;101(2):368–75.
66. Gaillard R, Steegers EA, Franco OH, Hofman A, Jaddoe VW.
Maternal weight gain in different periods of pregnancy and
childhood cardio-metabolic outcomes. The Generation R Study.
Int J Obes. 2015;39(4):677–85.
67. Kaar JL, Crume T, Brinton JT, Bischoff KJ, McDuffie R,
Dabelea D. Maternal obesity, gestational weight gain, and off-
spring adiposity: the exploring perinatal outcomes among chil-
dren study. J Pediatrics. 2014;165(3):509–15.
68. Fraser A, Tilling K, Macdonald-Wallis C, et al. Association of
maternal weight gain in pregnancy with offspring obesity and
metabolic and vascular traits in childhood. Circulation.
2010;121(23):2557–64.
69. Crozier SR, Inskip HM, Godfrey KM, et al. Weight gain in
pregnancy and childhood body composition: findings from the
Southampton Women’s Survey. Am J Clin Nutr.
2010;91(6):1745–51.
70. Oken E, Rifas-Shiman SL, Field AE, Frazier AL, Gillman MW.
Maternal gestational weight gain and offspring weight in ado-
lescence. Obstet Gynecol. 2008;112(5):999–1006.
71. Perng W, Gillman MW, Mantzoros CS, Oken E. A prospective
study of maternal prenatal weight and offspring cardiometabolic
health in midchildhood. Ann Epidemiol. 2014;24(11):793–800
e1.
72. Oostvogels AJ, Stronks K, Roseboom TJ, van der Post JA, van
Eijsden M, Vrijkotte TG. Maternal prepregnancy BMI, off-
spring’s early postnatal growth, and metabolic profile at age
5–6 years: the ABCD Study. J Clin Endocrinol Metab.
2014;99(10):3845–54.
73. Laitinen J, Jaaskelainen A, Hartikainen AL, et al. Maternal
weight gain during the first half of pregnancy and offspring
obesity at 16 years: a prospective cohort study. BJOG.
2012;119(6):716–23.
74. Hochner H, Friedlander Y, Calderon-Margalit R, et al. Associ-
ations of maternal prepregnancy body mass index and gesta-
tional weight gain with adult offspring cardiometabolic risk
factors: the Jerusalem Perinatal Family Follow-up Study. Cir-
culation. 2012;125(11):1381–9.
75. Tequeanes AL, Gigante DP, Assuncao MC, Chica DA, Horta
BL. Maternal anthropometry is associated with the body mass
1150 R. Gaillard
123
index and waist:height ratio of offspring at 23 years of age.
J Nutr. 2009;139(4):750–4.
76. Schack-Nielsen L, Michaelsen KF, Gamborg M, Mortensen EL,
Sorensen TI. Gestational weight gain in relation to offspring
body mass index and obesity from infancy through adulthood.
Int J Obes. 2010;34(1):67–74.
77. Hrolfsdottir L, Rytter D, Olsen SF, et al. Gestational weight gain
in normal weight women and offspring cardio-metabolic risk
factors at 20 years of age. Int J Obes. 2015;39(4):671–6.
78. Rooney BL, Mathiason MA, Schauberger CW. Predictors of
obesity in childhood, adolescence, and adulthood in a birth
cohort. Matern Child Health J. 2011;15(8):1166–75.
79. Mamun AA, O’Callaghan M, Callaway L, Williams G, Najman
J, Lawlor DA. Associations of gestational weight gain with
offspring body mass index and blood pressure at 21 years of
age: evidence from a birth cohort study. Circulation.
2009;119(13):1720–7.
80. Reynolds RM, Allan KM, Raja EA, et al. Maternal obesity
during pregnancy and premature mortality from cardiovascular
event in adult offspring: follow-up of 1 323 275 person years.
BMJ. 2013;347:f4539.
81. Frisell T, Oberg S, Kuja-Halkola R, Sjolander A. Sibling com-
parison designs: bias from non-shared confounders and mea-
surement error. Epidemiology. 2012;23(5):713–20.
82. Kral JG, Biron S, Simard S, et al. Large maternal weight loss
from obesity surgery prevents transmission of obesity to chil-
dren who were followed for 2 to 18 years. Pediatrics.
2006;118(6):e1644–9.
83. Smith J, Cianflone K, Biron S, et al. Effects of maternal surgical
weight loss in mothers on intergenerational transmission of
obesity. J Clin Endocrinol Metab. 2009;94(11):4275–83.
84. Ludwig DS, Rouse HL, Currie J. Pregnancy weight gain and
childhood body weight: a within-family comparison. PLoS Med.
2013;10(10):e1001521.
85. Lawlor DA, Lichtenstein P, Langstrom N. Association of mater-
nal diabetes mellitus in pregnancy with offspring adiposity into
early adulthood: sibling study in a prospective cohort of 280,866
men from 248,293 families. Circulation. 2011;123(3):258–65.
86. Lawlor DA, Lichtenstein P, Fraser A, Langstrom N. Does
maternal weight gain in pregnancy have long-term effects on
offspring adiposity? A sibling study in a prospective cohort of
146,894 men from 136,050 families. Am J Clin Nutr.
2011;94(1):142–8.
87. Brion MJ. Commentary: can maternal-paternal comparisons
contribute to our understanding of maternal pre-pregnancy
obesity and its association with offspring cognitive outcomes?
Int J Epidemiol. 2013;42(2):518–9.
88. Patro B, Liber A, Zalewski B, Poston L, Szajewska H, Koletzko
B. Maternal and paternal body mass index and offspring obesity:
a systematic review. Ann Nutr Metab. 2013;63(1–2):32–41.
89. Smith GD, Ebrahim S. Mendelian randomization: prospects,
potentials, and limitations. Int J Epidemiol. 2004;33(1):30–42.
90. Tanvig M, Vinter CA, Jorgensen JS, et al. Effects of lifestyle
intervention in pregnancy and anthropometrics at birth on off-
spring metabolic profile at 2.8 years: results from the Lifestyle in
Pregnancy and Offspring (LiPO) study. J Clin Endocrinol
Metab. 2015;100(1):175–83.
91. Poston L. Maternal obesity, gestational weight gain and diet as
determinants of offspring long term health. Best Pract Res Clin
Endocrinol Metab. 2012;26(5):627–39.
92. Drake AJ, Reynolds RM. Impact of maternal obesity on off-
spring obesity and cardiometabolic disease risk. Reproduction.
2010;140(3):387–98.
93. Lawlor DA. The Society for Social Medicine John Pemberton
Lecture 2011. Developmental overnutrition—an old hypothesis
with new importance? Int J Epidemiol. 2013;42(1):7–29.
94. Parlee SD, MacDougald OA. Maternal nutrition and risk of
obesity in offspring: the Trojan horse of developmental plas-
ticity. Biochim Biophys Acta. 2014;1842(3):495–506.
95. Murrin C, Shrivastava A, Kelleher CC. Lifeways Cross-gener-
ation Cohort Study Steering G. Maternal macronutrient intake
during pregnancy and 5 years postpartum and associations with
child weight status aged five. Eur J Clin Nutr. 2013;67(6):670–9.
96. Moon RJ, Harvey NC, Robinson SM, et al. Maternal plasma
polyunsaturated fatty acid status in late pregnancy is associated
with offspring body composition in childhood. J Clin Endocrinol
Metab. 2013;98(1):299–307.
97. de Vries PS, Gielen M, Rizopoulos D, et al. Association between
polyunsaturated fatty acid concentrations in maternal plasma
phospholipids during pregnancy and offspring adiposity at age
7: the MEFAB cohort. Prostaglandins Leukot Essent Fatty
Acids. 2014;91(3):81–5.
98. Donahue SM, Rifas-Shiman SL, Gold DR, Jouni ZE, Gillman
MW, Oken E. Prenatal fatty acid status and child adiposity at
age 3 y: results from a US pregnancy cohort. Am J Clin Nutr.
2011;93(4):780–8.
99. Okubo H, Crozier SR, Harvey NC, et al. Maternal dietary gly-
cemic index and glycemic load in early pregnancy are associated
with offspring adiposity in childhood: the Southampton
Women’s Survey. Am J Clin Nutr. 2014;100(2):676–83.
100. Brion MJ, Ness AR, Rogers I, et al. Maternal macronutrient and
energy intakes in pregnancy and offspring intake at 10 y:
exploring parental comparisons and prenatal effects. Am J Clin
Nutr. 2010;91(3):748–56.
101. Nelson SM, Matthews P, Poston L. Maternal metabolism and
obesity: modifiable determinants of pregnancy outcome. Hum
Reprod Update. 2010;16(3):255–75.
102. Bartha JL, Marin-Segura P, Gonzalez-Gonzalez NL, Wagner F,
Aguilar-Diosdado M, Hervias-Vivancos B. Ultrasound evalua-
tion of visceral fat and metabolic risk factors during early
pregnancy. Obesity. 2007;15(9):2233–9.
103. O’Tierney-Ginn P, Presley L, Myers S, Catalano P. Placental
growth response to maternal insulin in early pregnancy. J Clin
Endocrinol Metab. 2015;100(1):159–65.
104. Corrigan N, Brazil DP, McAuliffe F. Fetal cardiac effects of
maternal hyperglycemia during pregnancy. Birth Defects Res A.
2009;85(6):523–30.
105. Poston L. Developmental programming and diabetes—the
human experience and insight from animal models. Best Pract
Res Clin Endocrinol Metab. 2010;24(4):541–52.
106. Group HSCR, Metzger BE, Lowe LP, et al. Hyperglycemia and
adverse pregnancy outcomes. N Engl J Med. 2008;358(19):
1991–2002.
107. Patel S, Fraser A, Davey Smith G, et al. Associations of ges-
tational diabetes, existing diabetes, and glycosuria with off-
spring obesity and cardiometabolic outcomes. Diabetes Care.
2012;35(1):63–71.
108. Kubo A, Ferrara A, Windham GC, et al. Maternal hyper-
glycemia during pregnancy predicts adiposity of the offspring.
Diabetes Care. 2014;37(11):2996–3002.
109. Regnault N, Gillman MW, Rifas-Shiman SL, Eggleston E, Oken E.
Sex-specific associations of gestational glucose tolerance with
childhood body composition. Diabetes Care. 2013;36(10):3045–53.
110. Nehring I, Chmitorz A, Reulen H, von Kries R, Ensenauer R.
Gestational diabetes predicts the risk of childhood overweight
and abdominal circumference independent of maternal obesity.
Diabet Med. 2013;30(12):1449–56.
111. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure
to diabetes conveys risks for type 2 diabetes and obesity: a study
of discordant sibships. Diabetes. 2000;49(12):2208–11.
112. Whyte K, Kelly H, O’Dwyer V, Gibbs M, O’Higgins A, Turner
MJ. Offspring birth weight and maternal fasting lipids in women
Maternal obesity during pregnancy and cardiovascular development and disease in the offspring 1151
123
screened for gestational diabetes mellitus (GDM). Eur J Obstet
Gynecol Reprod Biol. 2013;170(1):67–70.
113. Di Cianni G, Miccoli R, Volpe L, et al. Maternal triglyceride
levels and newborn weight in pregnant women with normal
glucose tolerance. Diabet Med. 2005;22(1):21–5.
114. Kalkhoff RK, Kandaraki E, Morrow PG, Mitchell TH, Kelber S,
Borkowf HI. Relationship between neonatal birth weight and
maternal plasma amino acid profiles in lean and obese nondia-
betic women and in type I diabetic pregnant women. Metab,
Clin Exp. 1988;37(3):234–9.
115. Schaefer-Graf UM, Graf K, Kulbacka I, et al. Maternal lipids as
strong determinants of fetal environment and growth in preg-
nancies with gestational diabetes mellitus. Diabetes Care.
2008;31(9):1858–63.
116. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB.
Elevated C-reactive protein levels in overweight and obese
adults. JAMA, J Am Med Assoc. 1999;282(22):2131–5.
117. Davi G, Guagnano MT, Ciabattoni G, et al. Platelet activation in
obese women: role of inflammation and oxidant stress. JAMA, J
Am Med Assoc. 2002;288(16):2008–14.
118. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA,
Sattar N. Maternal obesity is associated with dysregulation of
metabolic, vascular, and inflammatory pathways. J Clin Endo-
crinol Metab. 2002;87(9):4231–7.
119. Rusterholz C, Hahn S, Holzgreve W. Role of placentally pro-
duced inflammatory and regulatory cytokines in pregnancy and
the etiology of preeclampsia. Semin immunopathol. 2007;29(2):
151–62.
120. Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy
stimulates macrophage accumulation and inflammation in the
placenta. Placenta. 2008;29(3):274–81.
121. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S.
Gestational diabetes induces placental genes for chronic stress
and inflammatory pathways. Diabetes. 2003;52(12):2951–8.
122. Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M,
Ferrell WR. Longitudinal assessment of maternal endothelial
function and markers of inflammation and placental function
throughout pregnancy in lean and obese mothers. J Clin Endo-
crinol Metab. 2007;92(3):969–75.
123. Ernst GD, de Jonge LL, Hofman A, et al. C-reactive protein
levels in early pregnancy, fetal growth patterns, and the risk for
neonatal complications: the Generation R Study. Am J Obstet
Gynecol. 2011;205(2):132 e1-12.
124. Radaelli T, Uvena-Celebrezze J, Minium J, Huston-Presley L,
Catalano P, Hauguel-de Mouzon S. Maternal interleukin-6:
marker of fetal growth and adiposity. J Soc Gynecol Investig.
2006;13(1):53–7.
125. Danielsen I, Granstrom C, Rytter D, et al. Subclinical inflam-
mation during third trimester of pregnancy was not associated
with markers of the metabolic syndrome in young adult off-
spring. Obesity. 2014;22(5):1351–8.
126. Alfaradhi MZ, Ozanne SE. Developmental programming in
response to maternal overnutrition. Front Genet. 2011;2:27.
127. Hanson M, Godfrey KM, Lillycrop KA, Burdge GC, Gluckman
PD. Developmental plasticity and developmental origins of non-
communicable disease: theoretical considerations and epigenetic
mechanisms. Prog Biophys Mol Biol. 2011;106(1):272–80.
128. Finer S, Mathews C, Lowe R, et al. Maternal gestational dia-
betes is associated with genome-wide DNA methylation varia-
tion in placenta and cord blood of exposed offspring. Hum Mol
Genet. 2015;24(11):3021–9.
129. Nomura Y, Lambertini L, Rialdi A, et al. Global methylation in
the placenta and umbilical cord blood from pregnancies with
maternal gestational diabetes, preeclampsia, and obesity. Reprod
Sci. 2014;21(1):131–7.
130. Bouchard L, Thibault S, Guay SP, et al. Leptin gene epigenetic
adaptation to impaired glucose metabolism during pregnancy.
Diabetes Care. 2010;33(11):2436–41.
131. Morales E, Groom A, Lawlor DA, Relton CL. DNA methylation
signatures in cord blood associated with maternal gestational
weight gain: results from the ALSPAC cohort. BMC Res Notes.
2014;7:278.
132. Yu ZB, Han SP, Zhu GZ, et al. Birth weight and subsequent risk
of obesity: a systematic review and meta-analysis. Obes Rev.
2011;12(7):525–42.
133. Nathanielsz PW, Poston L, Taylor PD. In utero exposure to
maternal obesity and diabetes: animal models that identify and
characterize implications for future health. Clin Perinatol.
2007;34(4):515–526, v.
134. Taylor PD, Samuelsson AM, Poston L. Maternal obesity and the
developmental programming of hypertension: a role for leptin.
Acta Physiol. 2014;210(3):508–23.
1152 R. Gaillard
123
